Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Drug Overdose can occur with multiple symptoms including sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Treatment includes antidote and activated charcoal.
The Drug Overdose pipeline market report provides a comprehensive overview of the therapeutics under development for Drug Overdose, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects.
Drug Overdose Pipeline Drugs Market by Key Targets
In the Drug Overdose pipeline drug market, the key targets are Mu Type Opioid Receptor, Delta Type Opioid Receptor, Kappa Type Opioid Receptor, Cannabinoid Receptor 1, Free Radical, Acetylcholinesterase, Calcium Activated Potassium Channel Subunit Alpha 1, and Opioid Receptor.
Key Targets in the Drug Overdose Pipeline Drugs Market
For more target insights, download a free report sample
Key MoA in the Drug Overdose Pipeline Drugs Market
Mu Type Opioid Receptor Antagonist has the highest share in the Drug Overdose Pipeline Drugs Market. The other key mechanisms of action are Delta Type Opioid Receptor Antagonist, Kappa Type Opioid Receptor Antagonist, Cannabinoid Receptor 1 Antagonist, Free Radical Scavenger, Acetylcholinesterase Inhibitor, Calcium Activated Potassium Channel Subunit Alpha 1 Blocker, and Opioid Receptor Antagonist.
Drug Overdose Pipeline Drugs Market Analysis, by MoA
To get more insights on key MoA, download a free sample report
Drug Overdose Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Drug Overdose pipeline drug market are Nasal, Intravenous, Oral, Buccal, Subcutaneous, Parenteral, Intramuscular, and Transdermal. Nasal has the maximum number of pipeline products.
Drug Overdose Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Drug Overdose Pipeline Drugs Market
The key molecule type in the Drug Overdose pipeline drugs market are Small Molecule, Monoclonal Antibody, Antibody, Conjugate Vaccine, and Subunit Vaccine. Small molecule has the maximum number of pipeline products.
Drug Overdose Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Major Companies in the Drug Overdose Pipeline Drugs Market
Some of the major companies in the Drug Overdose pipeline drugs market are Emergent BioSolutions Inc, Opiant Pharmaceuticals Inc, Egetis Therapeutics AB, InterveXion Therapeutics LLC, Klaria Pharma Holding AB, Orexo AB, Vernalis R&D Ltd, Amphastar Pharmaceuticals Inc, Avior Bio Inc, and Clear Scientific LLC.
Drug Overdose Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Drug Overdose Pipeline Drugs Market Overview
| Key Targets | Mu Type Opioid Receptor, Delta Type Opioid Receptor, Kappa Type Opioid Receptor, Cannabinoid Receptor 1, Free Radical, Acetylcholinesterase, Calcium Activated Potassium Channel Subunit Alpha 1, and Opioid Receptor |
| Key Mechanisms of Action | Mu Type Opioid Receptor Antagonist, Delta Type Opioid Receptor Antagonist, Kappa Type Opioid Receptor Antagonist, Cannabinoid Receptor 1 Antagonist, Free Radical Scavenger, Acetylcholinesterase Inhibitor, Calcium Activated Potassium Channel Subunit Alpha 1 Blocker, and Opioid Receptor Antagonist |
| Key Routes of Administration | Nasal, Intravenous, Oral, Buccal, Subcutaneous, Parenteral, Intramuscular, and Transdermal |
| Key Molecule Types | Small Molecule, Monoclonal Antibody, Antibody, Conjugate Vaccine, and Subunit Vaccine |
| Major Companies | Emergent BioSolutions Inc, Opiant Pharmaceuticals Inc, Egetis Therapeutics AB, InterveXion Therapeutics LLC, Klaria Pharma Holding AB, Orexo AB, Vernalis R&D Ltd, Amphastar Pharmaceuticals Inc, Avior Bio Inc, and Clear Scientific LLC |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Drug Overdose
- The pipeline guide reviews pipeline therapeutics for Drug Overdose by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Drug Overdose therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Drug Overdose therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Drug Overdose
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Drug Overdose
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Drug Overdose pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Avior Bio Inc
Clear Scientific LLC
Crossject SA
Egetis Therapeutics AB
Emergent BioSolutions Inc
Enalare Therapeutics Inc
Fab’entech SA
Hepione Therapeutics Inc
Icure Pharmaceutical Inc
InterveXion Therapeutics LLC
Klaria Pharma Holding AB
Mucodel Pharma LLC
Nasus Pharma Ltd
Opiant Pharmaceuticals Inc
Orexo AB
ResQ Pharma Inc
Sparian Biosciences Inc
Vallon Pharmaceuticals Inc
Vernalis R&D Ltd
Worphmed Srl
Table of Contents
Frequently asked questions
-
What are the key targets in the Drug Overdose pipeline drug market?
In the Drug Overdose pipeline drugs market the key targets are Mu Type Opioid Receptor, Delta Type Opioid Receptor, Kappa Type Opioid Receptor, Cannabinoid Receptor 1, Free Radical, Acetylcholinesterase, Calcium Activated Potassium Channel Subunit Alpha 1, and Opioid Receptor.
-
What are the key mechanisms of action in the Drug Overdose pipeline drugs market?
In the Drug Overdose pipeline drugs market the key mechanisms of action are Mu Type Opioid Receptor Antagonist, Delta Type Opioid Receptor Antagonist, Kappa Type Opioid Receptor Antagonist, Cannabinoid Receptor 1 Antagonist, Free Radical Scavenger, Acetylcholinesterase Inhibitor, Calcium Activated Potassium Channel Subunit Alpha 1 Blocker, and Opioid Receptor Antagonist.
-
What are the key routes of administration in the Drug Overdose pipeline drugs market?
The key routes of administration in the Drug Overdose pipeline drug market are Nasal, Intravenous, Oral, Buccal, Subcutaneous, Parenteral, Intramuscular, and Transdermal. Nasal has the maximum number of pipeline products.
-
What are the key molecule types in the Drug Overdose pipeline drugs market?
The key molecule types in the Drug Overdose pipeline drug market are Small Molecule, Monoclonal Antibody, Antibody, Conjugate Vaccine, and Subunit Vaccine.
-
What are the major companies in the Drug Overdose pipeline drugs market?
In the Drug Overdose pipeline drugs market the major companies are Emergent BioSolutions Inc, Opiant Pharmaceuticals Inc, Egetis Therapeutics AB, InterveXion Therapeutics LLC, Klaria Pharma Holding AB, Orexo AB, Vernalis R&D Ltd, Amphastar Pharmaceuticals Inc, Avior Bio Inc, and Clear Scientific LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Toxicology reports